Common Contracts
3 similar null contracts by CytomX Therapeutics, Inc.
September 30 Carlos Campoy Re: Employment Separation Dear Carlos:CytomX Therapeutics, Inc. • November 8th, 2022 • Pharmaceutical preparations
This letter (the "Agreement") confirms the terms of the offer made to you by CytomX Therapeutics, Inc. (the “Company”) regarding the separation of your employment, effective as of September 30, 2022 (the “Separation Date”) as a result of a reduction in force. If you sign and return this letter to me on or before November 14, 2022 it shall become a binding agreement between you and the Company, and you will receive the separation benefits described herein. If you do not timely sign and return it, or if you revoke it in accordance with the terms of Section 7(d), below, you will receive no payments or benefits from the Company after the Separation Date, including but not limited to Company-paid COBRA premium coverage.
September 30, 2022 Alison Hannah, M.D. Re: Employment Separation Dear Alison:CytomX Therapeutics, Inc. • November 8th, 2022 • Pharmaceutical preparations
This letter (the "Agreement") confirms the terms of the offer made to you by CytomX Therapeutics, Inc. (the “Company”) regarding the separation of your employment, effective as of September 30, 2022 (the “Separation Date”) as a result of a reduction in force. If you sign and return this letter to me on or before November 14, 2022 it shall become a binding agreement between you and the Company, and you will receive the separation benefits described herein. If you do not timely sign and return it, or if you revoke it in accordance with the terms of Section 7(d), below, you will receive no payments or benefits from the Company after the Separation Date, including but not limited to Company-paid COBRA premium coverage.
September 12, 2022 Amy C. Peterson, M.D. Re: Employment Separation Dear Amy:CytomX Therapeutics, Inc. • November 8th, 2022 • Pharmaceutical preparations
This letter (the "Agreement") confirms the terms of the offer made to you by CytomX Therapeutics, Inc. (the “Company”) regarding the separation of your employment, effective as of September 12, 2022 (the “Separation Date”) as a result of a reduction in force. If you sign and return this letter to me on or before October 27, 2022 it shall become a binding agreement between you and the Company, and you will receive the separation benefits described herein. If you do not timely sign and return it, or if you revoke it in accordance with the terms of Section 7(d), below, you will receive no payments or benefits from the Company after the Separation Date, including but not limited to Company-paid COBRA premium coverage.
